American College of Cardiology (ACC)
New Orleans Ernest N. Morial Convention Center
New Orleans, LA
Parkinson Study Group (PSG)
Sheraton Grand Wild Horse Pass
Phoenix, AZ
American Academy of Neurology (AAN)
Pennsylvania Convention Center
Philadelphia, PA
Heart Rhythm Society (HRS)
Moscone Center
San Francisco, CA
Movement Disorders Society (MDS) Fellows
Aspen, CO
American Autonomic Society (AAS)
Wyndham Grand Clearwater Beach
Clearwater FL
Pan American Section - Movement Disorder Society (PAS/MDS)
Miami, FL
American College of Cardiology (ACC)
Chicago, IL
American Academy of Neurology (AAN)
Toronto, CAN
Heart Rhythm Society (HRS)
San Diego, CA
Movement Disorders Society (MDS) Fellows
Movement Disorders Society (MDS) Annual Congress
Philadelphia, PA
American Autonomic Society (AAS)
Maui, HI
Please see Important Safety Information, including Boxed Warning for supine hypertension.
For more information, see the full Prescribing Information.
Indications and Usage
NORTHERA (droxidopa) is indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson’s disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of NORTHERA should be assessed periodically.
Important Safety Information
WARNING: SUPINE HYPERTENSION
Monitor supine blood pressure prior to and during treatment and more frequently when increasing doses. Elevating the head of the bed lessens the risk of supine hypertension, and blood pressure should be measured in this position. If supine hypertension cannot be managed by elevation of the head of the bed, reduce or discontinue NORTHERA.
CONTRAINDICATIONS
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
DRUG INTERACTIONS
USE IN SPECIFIC POPULATIONS
For more information, please see the full Prescribing Information, including Boxed Warning for supine hypertension.